Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-26

FDA Approved: WINLEVI — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved WINLEVI (clascoterone) cream for the treatment of acne vulgaris in patients 12 years and older. The drug represents a first-in-class topical antian…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Winlevi (clascoterone)

Snippet

ORIG AP for WINLEVI (CLASCOTERONE)